128 related articles for article (PubMed ID: 3212599)
1. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
Heidrich H; Ranft J
Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
[No Abstract] [Full Text] [Related]
2. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
Heidrich VH; Baethke R; Beyer KH
Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
[TBL] [Abstract][Full Text] [Related]
3. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch S
Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
[No Abstract] [Full Text] [Related]
4. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
5. [Thrombocyte function in parenteral naftidrofuryl therapy].
Janka HU; Rinninger F; Mehnert H
Ther Ggw; 1982 Jul; 121(7):422-33. PubMed ID: 7051401
[No Abstract] [Full Text] [Related]
6. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Ratschow R
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
[TBL] [Abstract][Full Text] [Related]
7. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
Ranft J; Heidrich H; Lammersen T
J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
[TBL] [Abstract][Full Text] [Related]
8. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
10. [Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound].
Weidinger P
Med Welt; 1983 Apr; 34(17):531-4. PubMed ID: 6865725
[No Abstract] [Full Text] [Related]
11. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
12. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
Krupiński K; Bielawiec M; Szpak A; Płonowski A
Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
[TBL] [Abstract][Full Text] [Related]
13. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
Rey JL; Quiret JC; Gamain J; Errasti M
Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747
[No Abstract] [Full Text] [Related]
14. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
Ciammaichella A; Solitro A; Arcuri P
Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
[No Abstract] [Full Text] [Related]
15. [Effect of naftidrofuryl (praxilene) on the peripheral cerebral circulation. Dynamometric and dynamographic control].
Barut C; Roch MT
Bull Soc Ophtalmol Fr; 1974; 74(7-8):771-8. PubMed ID: 4469472
[No Abstract] [Full Text] [Related]
16. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
Heidrich H; Wehselau H
Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
[No Abstract] [Full Text] [Related]
17. Naftidrofuryl (Praxilene) in peripheral vascular disease.
Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
[No Abstract] [Full Text] [Related]
18. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
Jung F; Wolf S; Kiesewetter H
Arzneimittelforschung; 1989 Oct; 39(10):1277-80. PubMed ID: 2610721
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of femoral vasodilatator effects of naftidrofuryl and nicergoline on dog (author's transl)].
Luong TN; Depin JC
J Pharmacol; 1981; 12(3):263-75. PubMed ID: 7289623
[TBL] [Abstract][Full Text] [Related]
20. Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
Tan OT; Gaylarde PM; Sarkany I
Australas J Dermatol; 1978 Aug; 19(2):51-3. PubMed ID: 728015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
